T cells, retrovirally transduced with a CSPG4-specific CAR, exerted potent cytotoxicity in various CSPG4-expressing tumors, such as melanoma, breast cancer, mesothelioma, glioblastoma, and osteosarcoma [35,36], in animal models. Here, CSPG4 is linked to osteosarcoma.